Preclinical assessment of the absorption, distribution, metabolism and excretion of GDC-0449 (2-chloro-N-(4-chloro-3-(pyridin-2-yl)phenyl)-4-(methylsulfonyl)benzamide), an orally bioavailable systemic Hedgehog signalling pathway inhibitor
Keyword(s):
Keyword(s):
2017 ◽
Vol 15
(14)
◽
pp. 3046-3059
◽
Keyword(s):
2005 ◽
Vol 129
(5)
◽
pp. 1696-1710
◽
2018 ◽
Vol 21
(2)
◽
pp. 477-486
◽
2000 ◽
Vol 10
(20)
◽
pp. 1315-1318
◽